Investor Relations 2018-05-07T18:00:49+00:00

Vitro Diagnostics, Inc. (OTCPK:VODG)

Vitro Diagnostics dba Vitro Biopharma develops and commercialize adult stem cell technology for applications in stem cell research, drug development and therapeutic products for treatment a vast variety of diseases and conditions. We offer a series of tools to promote the development of stem cell research and clinical applications focusing on Mesenchymal Stem Cells (MSCs).

Company Information

Vitro Biopharma
4621 Technology Drive
Golden, CO 80403

Investor Relations

John Evans
CFO & Director
[email protected]
(303) 999-2137

Transfer Agent

Securities Transfer Corporation
2591 Dallas Parkway, Suite 102
Frisco, TX 75034

Share Statistics

Outstanding: 21,431,822

(As of December 19, 2017)

VODG 0,06 0,00 0,00%